Skip to main content
Professional Technical IVT

CAH

Also written as: CAH — Congenital Adrenal Hyperplasia

Inherited disorders affecting adrenal steroid synthesis, commonly causing ambiguous genitalia and growth abnormalities.

Full Definition

Congenital adrenal hyperplasia encompasses a group of autosomal recessive disorders characterized by defects in enzymes required for cortisol and aldosterone synthesis. The most common form, 21-hydroxylase deficiency, accounts for approximately 95% of cases and can present as classic salt-wasting, simple virilizing, or non-classic forms. Affected individuals may present with ambiguous genitalia in newborn females, precocious puberty, accelerated growth followed by short adult stature, and potentially life-threatening salt-wasting crises. Treatment involves glucocorticoid replacement therapy and, when necessary, mineralocorticoid supplementation. Long-term management requires careful monitoring of growth, pubertal development, and metabolic parameters.

Usage

Usage note: Always spell out 'congenital adrenal hyperplasia' on first use, followed by the abbreviation in parentheses.

In Context

  • "The newborn screening program detected elevated 17-hydroxyprogesterone levels, prompting evaluation for CAH." — Laboratory report
  • "Patients with CAH require lifelong glucocorticoid replacement therapy with careful dose titration during stress and illness." — Treatment protocol

Also known as

congenital adrenal hyperplasia adrenogenital syndrome

Don't confuse with

Cushing syndrome androgen insensitivity syndrome

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON